Leo James’ group, in the LMB’s PNAC Division, have characterised the defensive pathway TRIM21 uses to degrade a diverse range of pathogens, naming the mechanism antibody-directed xenophagy (ADX).
Read more about ADX & its potential for new therapies here: mrclmb.ac.uk/news-events/...
#LMBResearch
